Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer

By Torrisi Rosalba  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 431-441

Springer Publishing Company

Access to resources Recommend Favorite

A Randomised Study to Compare the Effect of the Luteinising Hormone Releasing Hormone (LHRH) Analogue Goserelin With or Without Tamoxifen in Pre- and Perimenopausal Patients With Advanced Breast Cancer

By Jonat W.   Kaufmann M.   Blamey R.W.   Howell A.   Collins J.P.   Coates A.   Eiermann W.   Janicke F.   Njordenskold B.   Forbes J.F.   Kolvenbag G.J.C.M.  

European Journal of Cancer, Vol. 31, Iss. 2, 1995-01 ,pp. : 137-142

Elsevier

Access to resources Recommend Favorite

LH-RH analogues in the treatment of young women with early breast cancer: Long-term follow-up of a phase II study

By  

International Journal of Oncology, Vol. 46, Iss. 3, 2015-01 ,pp. : 1354-1360

Spandidos Publications

Access to resources Recommend Favorite

Anastrozole (‘Arimidex’) versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: Results of the double-blind cross-over SAKK trial 21/95 - a sub-study of the TARGET (Tamoxifen or ‘Arimidex’ Randomized Group Efficacy and Tolerability) trial

By Thürlimann Beat   Hess Dagmar   Köberle Dieter   Senn Isabella   Ballabeni Pierluigi   Pagani Olivia   Perey Lucien   Aebi Stefan   Rochlitz Christoph   Goldhirsch Aron  

Breast Cancer Research and Treatment, Vol. 85, Iss. 3, 2004-06 ,pp. : 247-254

Springer Publishing Company

Access to resources Recommend Favorite

Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer

By Sverrisdottir Asgerdur  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 755-763

Springer Publishing Company

Access to resources Recommend Favorite